Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Immunother Cancer
Prif Awduron: Spahn, Jessica, Peng, Jing, Lorenzana, Edward, Kan, David, Hunsaker, Thomas, Segal, Ehud, Mautino, Mario, Brincks, Erik, Pirzkall, Andrea, Kelley, Sean, Mahrus, Sami, Liu, Liling, Dale, Stephanie, Quiason, Cristine, Jones, Elizabeth, Liu, Yichin, Latham, Sheerin, Salphati, Laurent, DeMent, Kevin, Merchant, Mark, Hatzivassiliou, Georgia
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2015
Pynciau:
Poster Presentation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4649373/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-3-S2-P303
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg